How COVID-19 booster shots could help in global fight against the virus
It’s unclear if everyone will need boosters, but early results are promising. Read Article
Entries by Morgana Souza
So you missed your 2nd COVID shot. Now what?
About 5 million Americans missed receiving their second dose of Pfizer or Moderna COVID-19 vaccine, according to Centers for Disease Control and Prevention data released on Sunday. Read Article
The Story of One Dose Inside the sprawling operational puzzle of bringing the Johnson & Johnson COVID vaccine to the public.
NYmag narrates a bit on how the Barouch lab contributed to the development of the JNJ single dose COVID vaccine. Read Article
An HIV lab’s pivot to develop a single-dose Covid-19 vaccine wins STAT Madness ‘Editors’ Pick’
The Barouch lab wins’ the 2021 STAT Madness Editors’ Pick for their pivot to develop a single-dose COVID-19 Vaccine. Read Article
A City in Brazil’s Amazon Rain Forest Is a Stark Warning about COVID to the Rest of the World
Manaus and cities like it will continue to generate dangerous viral variants if vaccination campaigns are not expanded to broadly reach all nations, rich or poor. Read Article
Plan to Ditch the Mask After Vaccination? Not So Fast.
It’s not clear how easily vaccinated people may spread the virus, but the answer to that question is coming soon. Until then, scientists urge caution. Read Article
Merck to help rival Johnson & Johnson make COVID-19 vaccine
The pharmaceutical giant Merck will help manufacture the newly authorized single-shot COVID-19 vaccine of its rival Johnson & Johnson. Read Article
The first Johnson & Johnson vaccines have been shipped. What’s next?
If Pfizer and Moderna threw the first big punches, if all goes well, Johnson & Johnson may be the blow that COVID never saw coming. NBC News Correspondent Ellison Barber, NBC News Reporter Vaughn Hillyard, and lead researcher for the Johnson & Johnson vaccine, Dr. Dan Barouch join Katy Tur to discuss. See Article
Covid-19 Vaccines Yield Breakthroughs in Long-Term Fight Against Infectious Disease
Researchers in gene-based technology produced a class of vaccines they believe can protect against all manner of outbreaks in the years to come. Read Article
